rs142094773

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000121.4(EPOR):​c.1462C>T​(p.Pro488Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0048 in 1,614,162 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 56 hom. )

Consequence

EPOR
NM_000121.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 1.51

Publications

19 publications found
Variant links:
Genes affected
EPOR (HGNC:3416): (erythropoietin receptor) This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
EPOR Gene-Disease associations (from GenCC):
  • primary familial polycythemia due to EPO receptor mutation
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075773597).
BP6
Variant 19-11378049-G-A is Benign according to our data. Variant chr19-11378049-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 268130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00533 (812/152286) while in subpopulation AMR AF = 0.0222 (339/15290). AF 95% confidence interval is 0.0202. There are 15 homozygotes in GnomAd4. There are 437 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 812 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000121.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPOR
NM_000121.4
MANE Select
c.1462C>Tp.Pro488Ser
missense
Exon 8 of 8NP_000112.1
EPOR
NR_033663.2
n.1819C>T
non_coding_transcript_exon
Exon 8 of 8

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPOR
ENST00000222139.11
TSL:1 MANE Select
c.1462C>Tp.Pro488Ser
missense
Exon 8 of 8ENSP00000222139.5
EPOR
ENST00000586890.5
TSL:1
n.*1205C>T
non_coding_transcript_exon
Exon 9 of 9ENSP00000467230.1
EPOR
ENST00000588681.5
TSL:1
n.1847C>T
non_coding_transcript_exon
Exon 8 of 8

Frequencies

GnomAD3 genomes
AF:
0.00530
AC:
806
AN:
152168
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00359
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00768
AC:
1930
AN:
251314
AF XY:
0.00657
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.0317
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0135
Gnomad NFE exome
AF:
0.00321
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00474
AC:
6929
AN:
1461876
Hom.:
56
Cov.:
32
AF XY:
0.00445
AC XY:
3235
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33480
American (AMR)
AF:
0.0311
AC:
1393
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00413
AC:
108
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00333
AC:
287
AN:
86258
European-Finnish (FIN)
AF:
0.0120
AC:
639
AN:
53404
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00378
AC:
4205
AN:
1112010
Other (OTH)
AF:
0.00445
AC:
269
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
431
861
1292
1722
2153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00533
AC:
812
AN:
152286
Hom.:
15
Cov.:
32
AF XY:
0.00587
AC XY:
437
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41564
American (AMR)
AF:
0.0222
AC:
339
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4828
European-Finnish (FIN)
AF:
0.0135
AC:
143
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00359
AC:
244
AN:
68018
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00372
Hom.:
11
Bravo
AF:
0.00545
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00581
AC:
705
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.00327
EpiControl
AF:
0.00290

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Primary familial polycythemia due to EPO receptor mutation (3)
-
-
1
Intellectual disability-hypotonic facies syndrome, X-linked, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L
PhyloP100
1.5
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.27
N
REVEL
Benign
0.12
Sift
Benign
0.36
T
Sift4G
Benign
0.11
T
Polyphen
0.010
B
Vest4
0.083
MVP
0.65
MPC
0.23
ClinPred
0.0076
T
GERP RS
3.8
Varity_R
0.033
gMVP
0.39
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142094773; hg19: chr19-11488725; API